GenomePrecision is based in Beijing, China. It has raised $45M in total funding. Latest round: Series C.
GenomePrecision is based in Beijing, China. GenomePrecision has raised $45M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in April 2021. The round record for GenomePrecision runs through 2021; nothing later has been disclosed. Investors on record include Sunland Fund, ZGC Co-Innovation Fund, Yinhe Yuanhui Investment, Guiyang Venture Capital, Zhejiang Juren Capital, Oriental Fortune Capital. 6 distinct backers are named across the disclosed rounds.
Every GenomePrecision figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Beijing at a similar stage.
Company funding database · Investor directory · Founder database · Mega-rounds 2026